Matrix metalloproteinases and their inhibitors in canine mammary tumors
<p>Abstract</p> <p>Background</p> <p>Malignant canine mammary tumors represent 50% of all neoplasms in female dogs. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are thought to be involved in tumor progression, and they are also as...
Main Authors: | Bradaschia Alice, Aricò Arianna, Garbisa Spiridione, Granato Anna, Zancanella Vanessa, Lopparelli Rosa, Castagnaro Massimo, Vascellari Marta, Morello Emanuela, Giantin Mery, Aresu Luca, Mutinelli Franco, Dacasto Mauro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-07-01
|
Series: | BMC Veterinary Research |
Online Access: | http://www.biomedcentral.com/1746-6148/7/33 |
Similar Items
-
Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach.
by: Silvia Da Ros, et al.
Published: (2018-01-01) -
Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors.
by: Eleonora Zorzan, et al.
Published: (2015-01-01) -
An In Vivo Whole-Transcriptomic Approach to Assess Developmental and Reproductive Impairments Caused by Flumequine in <i>Daphnia magna</i>
by: Edoardo Pietropoli, et al.
Published: (2023-05-01) -
Missense single nucleotide variants affecting CYP3A catalytic activity are present in Limousine cattle
by: Marianna Pauletto, et al.
Published: (2020-12-01) -
Sequencing and G-quadruplex folding of the canine proto-oncogene KIT promoter region: might dog be used as a model for human disease?
by: Silvia Da Ros, et al.
Published: (2014-01-01)